Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai-Jiang Tian

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular and Cellular Biochemistry|October 24, 2024
Omics research in atherosclerosisKai-Jiang Tian, Yu Yang, Guo-Shuai Chen, et al.
Current Pharmaceutical Design|August 17, 2022
Hippo: A New Hub for Atherosclerotic DiseaseXi-Yan Liu, Kun Zhou, Kai-Jiang Tian, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future prioritiesYe-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Sestrin2 in atherosclerosisZhen Tian, Bin-Jie Yan, Wen Luo, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Molecular and Cellular Biochemistry|October 23, 2021
Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathyNian-Hua Deng, Wen Luo, Dan-Dan Gui, et al.
Current Medicinal Chemistry|February 15, 2023
LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic DiseaseShao Ouyang, Zhi-Xiang Zhou, Hui-Ting Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biochemistry|October 24, 2024
Omics research in atherosclerosisKai-Jiang Tian, Yu Yang, Guo-Shuai Chen, et al.
Current Pharmaceutical Design|August 17, 2022
Hippo: A New Hub for Atherosclerotic DiseaseXi-Yan Liu, Kun Zhou, Kai-Jiang Tian, et al.
Frontiers in Cardiovascular Medicine|August 29, 2022
Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future prioritiesYe-Wei Yang, Nian-Hua Deng, Kai-Jiang Tian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 19, 2021
Sestrin2 in atherosclerosisZhen Tian, Bin-Jie Yan, Wen Luo, et al.
Cell Cycle (Georgetown, Tex.)|July 16, 2021
A promising field: regulating imbalance of EndMT in cardiovascular diseasesKun Zhou, Kai-Jiang Tian, Bin-Jie Yan, et al.
Molecular and Cellular Biochemistry|October 23, 2021
Hydrogen sulfide plays a potential alternative for the treatment of metabolic disorders of diabetic cardiomyopathyNian-Hua Deng, Wen Luo, Dan-Dan Gui, et al.
Current Medicinal Chemistry|February 15, 2023
LncRNA-mediated Modulation of Endothelial Cells: Novel Progress in the Pathogenesis of Coronary Atherosclerotic DiseaseShao Ouyang, Zhi-Xiang Zhou, Hui-Ting Liu, et al.
Pageof 1